Sentiment has been smashed on this stock, regardless of promises from emails which, let's face it, don't count. Support of this stock will rely on 1.) Fruition of blue sky with TAVR from partnership deal to further development 2.) CF+ and/or 3.) Getting rid of the vax for a chunk of change commensurate with our original investment.
Company may very well be CF+ at years end 2018 but that's a long way away. SP will drift lower in the meantime if none of the above happen.
response from WP - re 4C, page-59
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M | |||
| Open | High | Low | Value | Volume |
| $9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 298 | $9.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.85 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |